- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Berlin, Humboldt-Universität zu Berlin, Dissertation, 2024
- Keyword
-
Neuroblastom
- Event
-
Veröffentlichung
- (where)
-
Berlin
- (who)
-
Humboldt-Universität zu Berlin
- (when)
-
2024
- Creator
- Contributor
-
Henssen, Anton
Landthaler, Markus
Corbacioglu, Selim
- DOI
-
10.18452/29113
- URN
-
urn:nbn:de:kobv:11-110-18452/29823-9
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
2025-08-14T10:57:37+0200
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bei, Yi
- Henssen, Anton
- Landthaler, Markus
- Corbacioglu, Selim
- Humboldt-Universität zu Berlin
Time of origin
- 2024
Other Objects (12)
Collateral amplification under complete markets
Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells
Blinding the CYCLOPS - neuroblastoma vulnerabilities unveiled by 1p loss
Blinding the CYCLOPS - Neuroblastoma vulnerabilities unveiled by 1p loss
On the amplification role of collateral constraints
Identifying collateral and synthetic lethal vulnerabilities within the DNA-damage response
5′ ALK Amplification in Neuroblastoma: A Case Report
N-Myc-induced metabolic rewiring creates novel therapeutic vulnerabilities in neuroblastoma
Targeting a chemo-induced adaptive signaling circuit confers therapeutic vulnerabilities in pancreatic cancer
Multi-Parametric Drug Screening identifies Vulnerabilities and Combination Treatment Strategies for Neuroblastoma Subtypes
MYCN amplification in neuroblastoma: sequence, chromatin landscape, and genome remodeling
FGFR inhibition blocks NF-ĸB-dependent glucose metabolism and confers metabolic vulnerabilities in cholangiocarcinoma
Collateral amplification under complete markets
Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells
Blinding the CYCLOPS - neuroblastoma vulnerabilities unveiled by 1p loss
Blinding the CYCLOPS - Neuroblastoma vulnerabilities unveiled by 1p loss
On the amplification role of collateral constraints
Identifying collateral and synthetic lethal vulnerabilities within the DNA-damage response
5′ ALK Amplification in Neuroblastoma: A Case Report
N-Myc-induced metabolic rewiring creates novel therapeutic vulnerabilities in neuroblastoma
Targeting a chemo-induced adaptive signaling circuit confers therapeutic vulnerabilities in pancreatic cancer
Multi-Parametric Drug Screening identifies Vulnerabilities and Combination Treatment Strategies for Neuroblastoma Subtypes
MYCN amplification in neuroblastoma: sequence, chromatin landscape, and genome remodeling
FGFR inhibition blocks NF-ĸB-dependent glucose metabolism and confers metabolic vulnerabilities in cholangiocarcinoma
Collateral amplification under complete markets
Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells
Blinding the CYCLOPS - neuroblastoma vulnerabilities unveiled by 1p loss
Blinding the CYCLOPS - Neuroblastoma vulnerabilities unveiled by 1p loss
On the amplification role of collateral constraints
Identifying collateral and synthetic lethal vulnerabilities within the DNA-damage response
5′ ALK Amplification in Neuroblastoma: A Case Report
N-Myc-induced metabolic rewiring creates novel therapeutic vulnerabilities in neuroblastoma
Targeting a chemo-induced adaptive signaling circuit confers therapeutic vulnerabilities in pancreatic cancer
Multi-Parametric Drug Screening identifies Vulnerabilities and Combination Treatment Strategies for Neuroblastoma Subtypes
MYCN amplification in neuroblastoma: sequence, chromatin landscape, and genome remodeling